Ayuda
Ir al contenido

Dialnet


SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021)

    1. [1] Hospital Ramón y Cajal

      Hospital Ramón y Cajal

      Madrid, España

    2. [2] Hospital Universitario Reina Sofia

      Hospital Universitario Reina Sofia

      Cordoba, España

    3. [3] Complexo Hospitalario Universitario de Santiago

      Complexo Hospitalario Universitario de Santiago

      Santiago de Compostela, España

    4. [4] Department of Medical Oncology, Hospital Universitario Reina Sofia, Instituto Maimonides de Investigacion Biomedica, Universidad de Córdoba, Córdoba, Spain
    5. [5] Department of Medical Oncology, Hospital General Universitario, Ciudad Real, Spain
    6. [6] Department of Medical Oncology, Hospital Marina Baixa de Villajoyosa, Alicante, Spain
    7. [7] Department of Medical Oncology, Hospital Universitario Nuestra Señora de la Candelaria, Tenerife, Spain
    8. [8] Department of Medical Oncology, Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain
    9. [9] Department of Medical Oncology, Hospital Universitario de Jerez de la Frontera, Cádiz, Spain
    10. [10] Department of Medical Oncology, Hospital La Paz, P de la Castellana, 261 – 28046, Madrid, Spain
  • Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 24, Nº. 4 (April), 2022, págs. 693-702
  • Idioma: inglés
  • Enlaces
  • Resumen
    • The improvement of molecular alterations in cancer as well as the development of technology has allowed us to bring closer to clinical practice the determination of molecular alterations in the diagnosis and treatment of cancer. The use of multidetermination platforms is spreading in most Spanish hospitals. The objective of these clinical practice guides is to review their usefulness, and establish usage guidelines that guide their incorporation into clinical practice.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus

Opciones de compartir

Opciones de entorno